Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep94 | Adrenal medulla | ECE2017

Pheochromocytoma: a clinical and pathological study

Santacruz Elisa , Marengo Agustina Pia , Ortiz Andres , Peiro Inma , Pian Hector , Diez Juan Jose , Garcia-Sancho Paula , Villabona Carles , Iglesias Pedro

Objective: To assess clinical features, diagnosis, treatment and outcome in patients with pheochromocytoma surgically treated in the past 3 decades in two tertiary referral hospitals.Methods: A retrospective study on clinical and pathological characteristics, treatment, and outcome in patients with pheochromocytoma followed up in specialized neuroendocrinology units who underwent surgery in the period 1981–2016 was performed.R...

ea0041gp14 | Adrenal (1) | ECE2016

A Phase 3b, open-label, extension study to evaluate the long-term safety of once-daily, dual-release hydrocortisone (DR-HC) in patients with adrenal insufficiency (AI)

Nilsson Anna , Bergthorsdottir Ragnhildur , Burman Pia , Dahlqvist Per , Ekman Bertil , Eden Engstrom Britt , Ragnarsson Oskar , Skrtic Stanko , Wahlberg Jeanette , Achenbach Heinrich , Uddin Sharif , Marelli Claudio , Johannsson Gudmundur

Introduction: Glucocorticoid replacement for adrenal insufficiency (AI) remains inadequate, resulting in high morbidity, premature mortality and quality-of-life (QoL) impairment. This study investigated the long-term safety of dual-release hydrocortisone (DR-HC) in patients with primary AI.Methods: AI patients who completed a randomized, 3-month crossover study of once-daily DR-HC versus thrice-daily conventional immediate-release hydrocortisone plus a 6...

ea0037gp.02.04 | Adrenal (1) | ECE2015

Mortality in patients with incidentally discovered adrenal adenomas: the experience of San Luigi Hospital

Reimondo Giuseppe , Coletta Marcella , Peraga Giulia , Pia Anna , Pellegrino Micaela , Massaglia Chiara , Zaggia Barbara , Cosio Paolo , Mbachu Elena , Borretta Giorgio , Terzolo Massimo

Background: Adrenal incidentalomas are found in 3–7% of radiological series and many of them are adrenal adenomas. Autonomous cortisol secretion without clinical signs of overt hypercortisolism is a common finding in these patients. Studies reported metabolic derangement and increased cardiovascular risk associated with this state of subtle cortisol excess, however scanty data are available on the natural history of this condition.Aim: To assess the...

ea0035p655 | Female reproduction | ECE2014

Dietetic Therapy aimed to restart menstrual period in patients affected by anorexia nervosa in weight recovery

Policola Caterina , Musca Tania , Cefalo Chiara Maria Assunta , Siciliano Ludovico Luca , Lassandro Anna Pia , Meniconi Paola , Miggiano Giacinto Abele Donato , Casa Silvia Della

Anorexia Nervosa (AN) is a severe eating disorder characterized by significantly low body weight and fear of gaining weight. Amenorrhea is a very frequent feature in AN and it could persist after normalization of BMI. A well-represented fat mass and an adequate body composition (BC) are necessary for resumption of periods. Patients affected by AN, although in the remission phase, fear of becoming fat and refuse to gain weight. In our study we evaluated the effect of a normocal...

ea0070aep597 | Pituitary and Neuroendocrinology | ECE2020

High usage of drugs for neuropsychiatric morbidity in patients with Cushing´s disease before diagnosis and at 5–10 years follow-up – a nationwide study

Bengtsson Daniel , Ragnarsson Oskar , Berinder Katarina , Dahlqvist Per , Edén Engström Britt , Ekman Bertil , Höybye Charlotte , Wahlberg Jeanette , Burman Pia

Background: Neuropsychiatric symptoms and cognitive dysfunction are common in Cushing´s disease (CD), and seem only partly reversible after biochemical remission has been achieved.Aim: To investigate prescription of drugs associated with neuropsychiatric morbidity in a large national cohort of CD patients.Methods: Patients in the Swedish Pituitary Registry, diagnosed with CD between July 2006 and January 2018 were included, <e...

ea0029p31 | Adrenal cortex | ICEECE2012

Analysis of the glucocorticoid receptors polymorphism in patients with adrenal incidentaloma and patients with Cushing’s syndrome.

Reimondo G. , Giachino D. , Micossi I. , Berchialla P. , Varacalli S. , Allasino B. , Pia A. , Laino F. , Peraga G. , Cosio P. , Sciolla C. , De Marchi M. , Terzolo M.

The effects of glucocorticoids are mediated by the glucocorticoid receptors (GR) and some single nucleotide polymorphisms (SNPs) have been associated to enhanced sensitivity (N363S, BclI) or reduced sensitivity (ER22/23EK) to glucocorticoids.Aim of the present study was: 1) to assess the frequency of N363S, BclI and ER22/23EK in 46 patients with Cushing’s syndrome (CS) and 73 patients with adrenal incidentaloma (AI) compared to 186 healthy subjects;...

ea0022p422 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Juvenile hypertension due to coexistence of two very rare etiologies

Paragliola Rosa Maria , Ianni Francesca , Ricciato Maria Pia , Rosa Annapina De , Gallo Francesca , Locantore Pietro , Senes Paola , Rota Carlo Antonio , Pontecorvi Alfredo , Corsello Salvatore Maria

The coexistence of pheochromocytoma and hyperreninemia secondary to renal artery stenosis, which both represent important causes of juvenile hypertension, has been reported in Literature, while association between pheochromocytoma and reninoma has never been described.We evaluated a 24-year-old boy, which came to our attention for severe hypertension, unresponsive to anti-hypertensive polytherapy. In 1996, because of elevated calcitonin levels (180 pg/ml...

ea0020p221 | Endocrine tumours and neoplasia | ECE2009

Severe elevation of testosterone serum levels as unique finding in occult Sertoli-Leydig ovarian cell tumors

Paragliola Rosa Maria , Ricciato Maria Pia , Gallo Francesca , De Rosa Annapina , Senes Paola , Rota Carlo Antonio , Pontecorvi Alfredo , Corsello Salvatore Maria

Hirsutism affects 5–10% of women of reproductive age and may be the initial sign of an androgen disorder. We describe two cases of occult Sertoli-Leydig ovarian cell tumor suspected only on the basis of clinical and laboratory features.The first patient, a 42 year-old woman came to our attention for hirsutism. Several blood samples showed a very high testosterone concentration (~4 ng/ml), while non-ovarian causes of hyperandrogenism were excluded. A...

ea0016p398 | Neuroendocrinology | ECE2008

Genetic and clinical analyses in an Italian series of idiopathic hypogonadotropic hypogonadism

Bonomi Marco , Antonica Francesco , Cariboni Anna , Busnelli Marta , Pia Anna , Borretta Giorgio , Beck-Peccoz Paolo , Krausz Csilla , Maggi Roberto , Persani Luca

Idiopathic hypogonadotropic hypogonadism (IHH) is a rare and heterogeneous disease due to defects of GnRH secretion or action. IHH could be associated or not with anosmia respectively identifying the Kallmann’s syndrome (KS) or the normosmic IHH (nIHH). So far numerous causative genetic defects have been described, but very recent molecular genetic studies and animal models have opened novel perspectives. We are studying a series of 16 KS (14M,2F) and 18 nIHH (14M,4F). Al...

ea0014p326 | (1) | ECE2007

Partial withdrawal of levothyroxine to stimulate serum thyroglobulin (TG) in the follow-up of differentiated thyroid carcinoma (DTC)

Ianni Francesca , Rota Carlo Antonio , Corsello Salvatore Maria , Rosa Annapina De , Gallo Francesca , Paragliola Rosa Maria , Ingraudo Francesca , Ricciato Maria Pia , Maussier Maria Ludovica , Salvatori Massimo , Pontecorvi Alfredo

Aim: We compared effectiveness of partial withdrawal of levothyroxine (L-T4) to the use of recombinant human TSH (rhTSH) in preparation for Tg testing. We also evaluated clinical aspects and quality-of-life (QOL) during both regimens.Materials and methods: Ten consecutive patients, previously treated with total thyroidectomy and radioiodine ablation for DTC, underwent rhTSH protocol and, after 15 days, reduced their L-T4 dose by 50% for 5 weeks. At the f...